Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lombard, IL
NPI
1699847202
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2500 S Highland Avenue, Ste 104
Lombard, IL, 60148
Phone (630) 629-3610
Groups this clinician bills Medicare through
Medicare paid, 2024
$114K
1,357 services
Medicare patients, 2024
583
Average age 75
Drug cost, 2024
$2.2M
6,492 prescriptions
Company payments, 2025
$53K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Terrence F Swade was code 99214 (office e&m - established), 761 times for 420 patients. In total Terrence F Swade billed 1,357 services in 13 codes, and Medicare paid $114K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 761 | 420 | $90.48 | $69K |
| 99232 Hospital E&M - Subsequent | Facility | 304 | 64 | $63.15 | $19K |
| 99213 Office E&M - Established | Office | 119 | 105 | $60.17 | $7,160 |
| 99222 Hospital E&M - Initial | Facility | 55 | 50 | $104.66 | $5,756 |
| 99204 Office E&M - New | Office | 42 | 42 | $113.78 | $4,779 |
| 99223 Hospital E&M - Initial | Facility | 39 | 33 | $135.98 | $5,303 |
| 99239 Hospital Discharge Management | Facility | 23 | 17 | $92.22 | $2,121 |
By year: 2022 $183K for 2,489 services; 2023 $140K for 1,717 services; 2024 $114K for 1,357 services.
Medicare prescription drug claims, 2024
In 2024, the drug Terrence F Swade prescribed most often to Medicare patients was Levothyroxine Sodium, with 489 prescriptions and refills. In total Terrence F Swade wrote 6,492 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 489 | 1,393 | 136 | $6,447 |
| Atorvastatin Calcium Generic | 466 | 1,314 | 136 | $5,047 |
| Ozempic Semaglutide | 379 | 671 | 93 | $642K |
| Metformin Hcl Generic | 202 | 558 | 59 | $1,600 |
| Losartan Potassium Generic | 186 | 537 | 52 | $2,394 |
| Metformin Hcl Er Metformin Hcl | 181 | 514 | 54 | $2,443 |
| Amlodipine Besylate Generic | 169 | 459 | 45 | $1,380 |
| Synthroid Levothyroxine Sodium | 159 | 442 | 41 | $17K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 155 | 393 | 60 | $20K |
| Jardiance Empagliflozin | 143 | 326 | 33 | $188K |
| Mounjaro Tirzepatide | 138 | 167 | 29 | $172K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 128 | 296 | 44 | $20K |
| Glimepiride Generic | 108 | 317 | 29 | $1,570 |
| Novolog Flexpen Insulin Aspart | 85 | 209 | 37 | $27K |
| Tresiba Flextouch U-100 Insulin Degludec | 85 | 220 | 31 | $67K |
Brand drugs: 2,492 claims; generic drugs: 3,547 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Terrence F Swade $53K ($53K in general payments such as food, travel and fees) from 30 companies. The largest payer was Lilly USA, LLC with $27K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 63 | $27K |
| Novo Nordisk Inc NVO | 25 | $20K |
| Xeris Pharmaceuticals, Inc. | 20 | $3,217 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $333 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $314 |
| Corcept Therapeutics CORT | 17 | $308 |
| Recordati_rare_diseases_inc. | 12 | $275 |
| Amgen Inc. AMGN | 12 | $234 |
| Sequel Med Tech, LLC | 9 | $163 |
| Mannkind Corporation MNKD | 8 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.